ShockWave Medical Inc. (SWAV) is priced at $201.05 after the most recent trading session. At the very opening of the session, the stock price was $191.33 and reached a high price of $201.41, prior to closing the session it reached the value of $186.82. The stock touched a low price of $189.11.Recently in News on March 14, 2023, Shockwave Medical Announces U.S. Launch of New Peripheral IVL Catheter. Shockwave L⁶ Provides Physicians with Larger-Diameter Catheters to Expand Potential Treatment of Peripheral Vessels. You can read further details here
ShockWave Medical Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $320.54 on 10/26/22, with the lowest value was $113.36 for the same time period, recorded on 05/09/22.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
ShockWave Medical Inc. (SWAV) full year performance was 27.69%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, ShockWave Medical Inc. shares are logging -37.28% during the 52-week period from high price, and 77.36% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $113.36 and $320.54.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 696994 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the ShockWave Medical Inc. (SWAV) recorded performance in the market was -2.22%, having the revenues showcasing -12.61% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.66B, as it employees total of 1001 workers.
Specialists analysis on ShockWave Medical Inc. (SWAV)
During the last month, 0 analysts gave the ShockWave Medical Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 219.98, with a change in the price was noted -72.50. In a similar fashion, ShockWave Medical Inc. posted a movement of -26.50% for the period of last 100 days, recording 490,588 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SWAV is recording 0.05 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.05.
Trends and Technical analysis: ShockWave Medical Inc. (SWAV)
Raw Stochastic average of ShockWave Medical Inc. in the period of last 50 days is set at 60.76%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 54.63%. In the last 20 days, the company’s Stochastic %K was 27.29% and its Stochastic %D was recorded 23.79%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -2.22%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -29.94%, alongside a boost of 27.69% for the period of the last 12 months. The shares increased approximately by 1.37% in the 7-day charts and went down by 11.42% in the period of the last 30 days. Common stock shares were lifted by -12.61% during last recorded quarter.
